Ketamine has begun to solidify its place in the treatment of Major Depressive Disorder (MDD)across the globe.
Studied for its ability to loosen repressed emotional trauma and improve the effects of psychotherapy (MDMA, LSD, Psilocibin) since the early 70’s, ketamine has evolved into one of the most novel treatments for MDD in this century.
Since 2006 ketamine has been studied more in-depth for the treatment of “Treatment-Resistant Depression (TRD)” with a success rate that has climbed as high as 80% or better for many patients who suffer with this debilitating disease.
Thousands of people are placed on antidepressants such as SSRIs, SNRI, and other widely prescribed medications that are ineffective in reducing depressive symptoms. Many of these medications take weeks to months for effects to be realized and often end up starting all over, creating a vicious cycle of one failed treatment after another.
Comments